Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
22 avr. 2024 08h30 HE
|
Adial Pharmaceuticals, Inc
GLEN ALLEN, Va., April 22, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies...
ORYZON Secures Another Important Patent for its Lead CNS Asset, Vafidemstat
22 avr. 2024 08h00 HE
|
Oryzon Genomics, S.A.
Has received “Intention to Grant” from the European Patent Office For the treatment of aggression and social withdrawal MADRID, Spain and CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Oryzon...
Energy and Water Development Corp. Secures US Patent Application for Innovative Water Generation Technology
18 avr. 2024 08h00 HE
|
Energy and Water Development Corp.
MIAMI, April 18, 2024 (GLOBE NEWSWIRE) -- via IBN -- Energy and Water Development Corp. (“EAWD”) (OTCQB: EAWD), renowned for its sustainable water and energy solutions, proudly announces the filing...
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
16 avr. 2024 08h00 HE
|
Monopar Therapeutics Inc.
WILMETTE, Ill., April 16, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer...
Biomerica provides update on inFoods® IBS expansion
15 avr. 2024 07h47 HE
|
Biomerica, Inc.
- Expansion into new offices within current major groups, including Northeast and Ohio; Expansion into new major group in Texas. - Average quarterly increase in physicians prescribing inFoods more...
Bio-Path Holdings Expands Global Patent Portfolio
15 avr. 2024 07h00 HE
|
Bio-Path Holdings, Inc.
HOUSTON, April 15, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to...
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office
11 avr. 2024 09h31 HE
|
Fibrobiologics, Inc.
HOUSTON, April 11, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the...
Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge Reader
11 avr. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing...
Dalrada Financial Corporation Files Patent Application for Proprietary Technology that Creates Carbon Utility Tokens
10 avr. 2024 08h45 HE
|
Dalrada Financial Corp.
DFCO stakes its claim in the carbon market with unique software/hardware system that creates a solution for generating, validating, trading carbon tokens
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders
10 avr. 2024 07h17 HE
|
Clearmind Medicine Inc.
Vancouver, Canada, April 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a clinical- stage biotech company focused on discovery and...